Inhibitory effect of recombinant PF-4 on tumor growth and metastasis [66,67] is most likely consequence of tumor angiogenesis inhibition, because PF-4 does not inhibit proliferation of tumor cells in vitro[66]. This evidence concerns the gene PF4 and neoplasm.